A Phase II Randomized Double-Blind, Placebo Controlled Study in Patients with Critical Limb Ischemia to Evaluate the Safety and Efficacy of hSDF-1 plasmid (JVS-100) Post Open or Endovascular Revascularization (STOP-PAD Trial)
Todos os estudos aqui apresentados podem ser consultados na íntegra no site do American College of Cardiology
http://www.acc.org/education-and-meetings/image-and-slide-gallery
